- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Fast Test for Infant Infections
6 April 1998 7:30 pm
A new blood test can quickly reveal whether an infant has a bacterial infection. If the test, described in the March Journal of Pediatrics, can be developed for widespread use, it could help doctors save some infants' lives as well as millions of dollars in treatments for babies who seem to have infections.
Because newborns are so vulnerable to infections, doctors have to make snap decisions about whether a baby who looks sick actually needs an antibiotic. Often erring on the safe side, doctors end up treating 17 healthy babies for every one that is later confirmed to have an infection. For a decade, immunologists have searched for a molecule in the newborn immune system that could serve as a warning flag for an infection. But of the molecules tested so far, none has proven reliable.
Leonore Herzenberg, Erica Weirich, and their colleagues at Stanford University Medical Center set out to develop a simple blood test for the latest and most promising sentinel molecule, called CD11b. The molecule appears on the surface of neutrophils, a kind of immune cell, within 5 minutes after being exposed to a bacterial toxin called lipopoly saccharide. The researchers designed a fluorescent marker that clings to CD11b and can be viewed routinely under laserlight. They screened blood from 106 infants suspected to have an infection, or be at high risk for one. They also followed up with a proven, but slower, test for an infection that flags C-reactive protein (CRP). All 15 babies who tested positive for CRP, which is produced in large quantities during an infection, also were positive for CD11b. What's more, there were no false positive CD11b results.
If confirmed, the results "could ultimately change the way that physicians decide how to treat newborn infants," says Herzenberg. But Robert Baltimore, a pediatrician at Yale University Children's Hospital, isn't so sure. Although the test "has a very high predictive value," he says, it could suffer the fate of many previous lab tests for babies--doctors ignore them. "Very often they'll order the test and treat babies anyway," even if the test comes out negative, he says.